
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.135 | 52.1235521236 | 0.259 | 0.475 | 0.2417 | 21148800 | 0.35836321 | CS |
4 | 0.1319 | 50.3243037009 | 0.2621 | 0.475 | 0.24 | 5704676 | 0.35613092 | CS |
12 | -0.1523 | -27.8784550613 | 0.5463 | 0.7999 | 0.24 | 2319990 | 0.37265446 | CS |
26 | -0.3413 | -46.4164286686 | 0.7353 | 1.1099 | 0.24 | 1226323 | 0.44133262 | CS |
52 | -0.736 | -65.1327433628 | 1.13 | 1.87 | 0.24 | 606981 | 0.44967318 | CS |
156 | -3.046 | -88.5465116279 | 3.44 | 4.2 | 0.24 | 216327 | 0.59199343 | CS |
260 | -14.566 | -97.3663101604 | 14.96 | 19.56 | 0.24 | 438934 | 7.917098 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.